Workup for Elevated TSH to Diagnose Hypothyroidism
When a patient presents with elevated TSH, you should measure free T4 to distinguish between subclinical hypothyroidism (normal free T4) and overt hypothyroidism (low free T4). 1
Initial Diagnostic Testing
- Confirm elevated TSH with repeat testing after 3-6 weeks, as 30-60% of high TSH levels normalize on repeat testing 1
- Measure both TSH and free T4 to establish the diagnosis and determine severity 1, 2
- Consider testing for anti-TPO antibodies to identify autoimmune thyroiditis as the cause, which helps predict risk of progression to overt hypothyroidism 1, 3
- If TSH is undetectable and free T4 is normal, obtain a T3 level to evaluate for T3 toxicosis 4, 2
- Low TSH with low free T4 suggests central hypothyroidism, which requires evaluation for pituitary or hypothalamic disease 1, 5
Management Based on TSH Levels
For TSH >10 mIU/L:
- Initiate levothyroxine therapy regardless of symptoms 1, 6
- This level carries a higher risk of progression to overt hypothyroidism (approximately 5% per year) 1, 6
- Treatment prevents complications of hypothyroidism in patients who progress 1
For TSH 4.5-10 mIU/L with normal free T4:
- Consider treatment for symptomatic patients 1, 6
- Consider treatment for patients with infertility, goiter, or positive anti-TPO antibodies 6
- Monitor thyroid function every 6-12 months in asymptomatic patients without treatment 1, 5
- Always treat pregnant women or those planning pregnancy 1, 5, 6
Levothyroxine Dosing Guidelines
- For patients <70 years without cardiac disease or multiple comorbidities: 1.6 mcg/kg/day 4, 1
- For patients >70 years or with cardiac disease/multiple comorbidities: Start with 25-50 mcg/day and titrate gradually 4, 1
- Target TSH within the reference range (0.5-2.0 mIU/L) for primary hypothyroidism 1, 6
- Monitor TSH every 6-8 weeks while titrating hormone replacement 4, 1
- Once adequately treated, repeat testing every 6-12 months or if symptoms change 4, 1
Common Pitfalls to Avoid
- Failing to confirm elevated TSH with repeat testing before initiating treatment 1
- Undertreatment leading to persistent hypothyroid symptoms and adverse effects on cardiovascular function, lipid metabolism, and quality of life 1
- Overtreatment resulting in iatrogenic hyperthyroidism, which increases risk for osteoporosis, fractures, abnormal cardiac output, and ventricular hypertrophy 1
- Failing to recognize transient hypothyroidism, which may lead to unnecessary lifelong treatment 1
- Starting thyroid hormone replacement before ruling out adrenal insufficiency in patients with suspected central hypothyroidism 1, 6
- Adjusting doses too frequently before reaching steady state (should wait 6-8 weeks between adjustments) 1
Special Considerations
- In pregnancy: More aggressive normalization of TSH is warranted due to risks of adverse pregnancy outcomes 1, 6
- In elderly patients: Consider age-specific reference ranges and more conservative treatment approaches 1, 7
- In patients with cardiac disease: Use smaller dose increments (12.5 mcg) to avoid potential cardiac complications 1
- In patients with persistent symptoms despite normalized TSH: Consider checking free T4 to help interpret ongoing abnormal TSH levels, as TSH may take longer to normalize 4, 1